Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 10/20 | 0.42 |
| ▸ | RAB9A | P51151 | 10/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.42 |
| ▸ | HPGD | P15428 | 6/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11987979 | 0.94 | NPC1 (0.43) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL13230234 | 0.94 | S1PR1 (0.49) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL13230232 | 0.94 | S1PR1 (0.49) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL12680744 | 0.92 | S1PR1 (0.47) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL17948226 | 0.91 | S1PR1 (0.46) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL17948222 | 0.91 | S1PR1 (0.46) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL13427110 | 0.91 | S1PR1 (0.47) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL13230183 | 0.91 | S1PR1 (0.46) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL10001250 | 0.91 | S1PR1 (0.46) | S1PR1NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL13230198 | 0.91 | S1PR1 (0.46) | S1PR1NPC1RAB9ASMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273898-B2 | Oxadiazole derivative, light-emitting element, display device, lighting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-09-25 | — | — | US | disclosed |
| US-8273898-B2 | Oxadiazole derivative, light-emitting element, display device, lighting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20100244669-A1 | OXADIAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100244669-A1 | OXADIAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100244669-A1 | OXADIAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND ELECTRONIC DEVICE | DRD3, DRD2, OXA1L | S1PR1 3942/4885NPC1 4534/4885RAB9A 3235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.